Connection

Kumar Sambamurti to Humans

This is a "connection" page, showing publications Kumar Sambamurti has written about Humans.
Connection Strength

0.452
  1. Melatonin Treatment Enhances A? Lymphatic Clearance in a Transgenic Mouse Model of Amyloidosis. Curr Alzheimer Res. 2018; 15(7):637-642.
    View in: PubMed
    Score: 0.024
  2. When figures and data contradict text: MiR346 is apparently reduced in breast cancer tissue, contrary to claims by a paper's author. Gene. 2017 Nov 30; 635:46-47.
    View in: PubMed
    Score: 0.023
  3. Amyloid-beta protein clearance and degradation (ABCD) pathways and their role in Alzheimer's disease. Curr Alzheimer Res. 2015; 12(1):32-46.
    View in: PubMed
    Score: 0.019
  4. Preface. Turk J Med Sci. 2015; 45(5):i-ii.
    View in: PubMed
    Score: 0.019
  5. Evidence of a novel mechanism for partial ?-secretase inhibition induced paradoxical increase in secreted amyloid ? protein. PLoS One. 2014; 9(3):e91531.
    View in: PubMed
    Score: 0.018
  6. Targets for AD treatment: conflicting messages from ?-secretase inhibitors. J Neurochem. 2011 May; 117(3):359-74.
    View in: PubMed
    Score: 0.015
  7. Pigment epithelium-derived factor maintains retinal pigment epithelium function by inhibiting vascular endothelial growth factor-R2 signaling through gamma-secretase. J Biol Chem. 2009 Oct 30; 284(44):30177-86.
    View in: PubMed
    Score: 0.013
  8. Effects of a saturated fat and high cholesterol diet on memory and hippocampal morphology in the middle-aged rat. J Alzheimers Dis. 2008 Jun; 14(2):133-45.
    View in: PubMed
    Score: 0.012
  9. Value in development of a TAPIR-like mouse monoclonal antibody to Abeta. J Alzheimers Dis. 2008 Jun; 14(2):175-7.
    View in: PubMed
    Score: 0.012
  10. Beta-secretase: structure, function, and evolution. CNS Neurol Disord Drug Targets. 2008 Jun; 7(3):278-94.
    View in: PubMed
    Score: 0.012
  11. Geranylgeranyl pyrophosphate stimulates gamma-secretase to increase the generation of Abeta and APP-CTFgamma. FASEB J. 2008 Jan; 22(1):47-54.
    View in: PubMed
    Score: 0.012
  12. Genotoxicity in Alzheimer's disease: role of amyloid. Curr Alzheimer Res. 2006 Sep; 3(4):365-75.
    View in: PubMed
    Score: 0.011
  13. A partial failure of membrane protein turnover may cause Alzheimer's disease: a new hypothesis. Curr Alzheimer Res. 2006 Feb; 3(1):81-90.
    View in: PubMed
    Score: 0.010
  14. Cholesterol and Alzheimer's disease: clinical and experimental models suggest interactions of different genetic, dietary and environmental risk factors. Curr Drug Targets. 2004 Aug; 5(6):517-28.
    View in: PubMed
    Score: 0.009
  15. Gene structure and organization of the human beta-secretase (BACE) promoter. FASEB J. 2004 Jun; 18(9):1034-6.
    View in: PubMed
    Score: 0.009
  16. Amyloid precursor protein compartmentalization restricts beta-amyloid production: therapeutic targets based on BACE compartmentalization. J Mol Neurosci. 2004; 24(1):137-43.
    View in: PubMed
    Score: 0.009
  17. Rationale for the development of cholinesterase inhibitors as anti-Alzheimer agents. Curr Pharm Des. 2004; 10(25):3111-9.
    View in: PubMed
    Score: 0.009
  18. APH1, PEN2, and Nicastrin increase Abeta levels and gamma-secretase activity. Biochem Biophys Res Commun. 2003 Jun 06; 305(3):502-9.
    View in: PubMed
    Score: 0.009
  19. The role of the carboxyl-terminal fragments of amyloid precursor protein in Alzheimer's disease. Ann N Y Acad Sci. 2002 Nov; 973:334-9.
    View in: PubMed
    Score: 0.008
  20. The role of the adaptive immune system and T cell dysfunction in neurodegenerative diseases. J Neuroinflammation. 2022 Oct 08; 19(1):251.
    View in: PubMed
    Score: 0.008
  21. Lipid rafts play an important role in A beta biogenesis by regulating the beta-secretase pathway. J Mol Neurosci. 2002 Aug-Oct; 19(1-2):31-5.
    View in: PubMed
    Score: 0.008
  22. Advances in the cellular and molecular biology of the beta-amyloid protein in Alzheimer's disease. Neuromolecular Med. 2002; 1(1):1-31.
    View in: PubMed
    Score: 0.008
  23. Butyrylcholinesterase: an important new target in Alzheimer's disease therapy. Int Psychogeriatr. 2002; 14 Suppl 1:77-91.
    View in: PubMed
    Score: 0.008
  24. Sex-Specific Regulation of ?-Secretase: A Novel Estrogen Response Element (ERE)-Dependent Mechanism in Alzheimer's Disease. J Neurosci. 2022 02 09; 42(6):1154-1165.
    View in: PubMed
    Score: 0.008
  25. Indoles as essential mediators in the gut-brain axis. Their role in Alzheimer's disease. Neurobiol Dis. 2021 08; 156:105403.
    View in: PubMed
    Score: 0.008
  26. Rivastigmine modifies the a-secretase pathway and potentially early Alzheimer's disease. Transl Psychiatry. 2020 02 03; 10(1):47.
    View in: PubMed
    Score: 0.007
  27. Glycosylphosphatidylinositol-anchored proteins play an important role in the biogenesis of the Alzheimer's amyloid beta-protein. J Biol Chem. 1999 Sep 17; 274(38):26810-4.
    View in: PubMed
    Score: 0.007
  28. The secretion of amyloid beta-peptides is inhibited in the tacrine-treated human neuroblastoma cells. Brain Res Mol Brain Res. 1998 Nov 20; 62(2):131-40.
    View in: PubMed
    Score: 0.006
  29. ERAB contains a putative noncleavable signal peptide. Biochem Biophys Res Commun. 1998 Aug 19; 249(2):546-9.
    View in: PubMed
    Score: 0.006
  30. The heat shock/oxidative stress connection. Relevance to Alzheimer disease. Mol Chem Neuropathol. 1996 May-Aug; 28(1-3):21-34.
    View in: PubMed
    Score: 0.005
  31. Beta-Amyloid Precursor Protein (?APP) Processing in Alzheimer's Disease (AD) and Age-Related Macular Degeneration (AMD). Mol Neurobiol. 2015 Aug; 52(1):533-44.
    View in: PubMed
    Score: 0.005
  32. Amyloid-? precursor protein synthesis inhibitors for Alzheimer's disease treatment. Ann Neurol. 2014 Oct; 76(4):629-30.
    View in: PubMed
    Score: 0.005
  33. Evidence for lymphatic A? clearance in Alzheimer's transgenic mice. Neurobiol Dis. 2014 Nov; 71:215-9.
    View in: PubMed
    Score: 0.005
  34. Resolution of inflammation is altered in Alzheimer's disease. Alzheimers Dement. 2015 Jan; 11(1):40-50.e1-2.
    View in: PubMed
    Score: 0.005
  35. Incretin mimetics as pharmacologic tools to elucidate and as a new drug strategy to treat traumatic brain injury. Alzheimers Dement. 2014 Feb; 10(1 Suppl):S62-75.
    View in: PubMed
    Score: 0.005
  36. Synthesis of the Alzheimer drug Posiphen into its primary metabolic products (+)-N1-norPosiphen, (+)-N8-norPosiphen and (+)-N1, N8-bisnorPosiphen, their inhibition of amyloid precursor protein, a-Synuclein synthesis, interleukin-1? release, and cholinergic action. Antiinflamm Antiallergy Agents Med Chem. 2013; 12(2):117-28.
    View in: PubMed
    Score: 0.004
  37. Applying epigenetics to Alzheimer's disease via the latent early-life associated regulation (LEARn) model. Curr Alzheimer Res. 2012 Jun; 9(5):589-99.
    View in: PubMed
    Score: 0.004
  38. The Psen1-L166P-knock-in mutation leads to amyloid deposition in human wild-type amyloid precursor protein YAC transgenic mice. FASEB J. 2012 Jul; 26(7):2899-910.
    View in: PubMed
    Score: 0.004
  39. Human retinal pigment epithelium cells as functional models for the RPE in vivo. Invest Ophthalmol Vis Sci. 2011 Nov 04; 52(12):8614-20.
    View in: PubMed
    Score: 0.004
  40. Vitamin D3-enriched diet correlates with a decrease of amyloid plaques in the brain of A?PP transgenic mice. J Alzheimers Dis. 2011; 25(2):295-307.
    View in: PubMed
    Score: 0.004
  41. Drug discovery for neurodegenerative diseases: challenges and novel biochemical targets dedicated to the memory of Mark A. Smith for his inspiring contribution to Alzheimer's disease. J Alzheimers Dis. 2011; 24 Suppl 2:1-2.
    View in: PubMed
    Score: 0.004
  42. Higher incidence of mild cognitive impairment in familial hypercholesterolemia. Am J Med. 2010 Mar; 123(3):267-74.
    View in: PubMed
    Score: 0.003
  43. Neuronutrition and Alzheimer's disease. J Alzheimers Dis. 2010; 19(4):1123-39.
    View in: PubMed
    Score: 0.003
  44. GLP-1 receptor stimulation preserves primary cortical and dopaminergic neurons in cellular and rodent models of stroke and Parkinsonism. Proc Natl Acad Sci U S A. 2009 Jan 27; 106(4):1285-90.
    View in: PubMed
    Score: 0.003
  45. Challenges associated with metal chelation therapy in Alzheimer's disease. J Alzheimers Dis. 2009; 17(3):457-68.
    View in: PubMed
    Score: 0.003
  46. An increase in Abeta42 in the prefrontal cortex is associated with a reversal-learning impairment in Alzheimer's disease model Tg2576 APPsw mice. Curr Alzheimer Res. 2008 Aug; 5(4):385-91.
    View in: PubMed
    Score: 0.003
  47. Early-life events may trigger biochemical pathways for Alzheimer's disease: the "LEARn" model. Biogerontology. 2008 Dec; 9(6):375-9.
    View in: PubMed
    Score: 0.003
  48. Role of DNA dynamics in Alzheimer's disease. Brain Res Rev. 2008 Jun; 58(1):136-48.
    View in: PubMed
    Score: 0.003
  49. TNF-alpha inhibition as a treatment strategy for neurodegenerative disorders: new drug candidates and targets. Curr Alzheimer Res. 2007 Sep; 4(4):378-85.
    View in: PubMed
    Score: 0.003
  50. Taking down the unindicted co-conspirators of amyloid beta-peptide-mediated neuronal death: shared gene regulation of BACE1 and APP genes interacting with CREB, Fe65 and YY1 transcription factors. Curr Alzheimer Res. 2006 Dec; 3(5):475-83.
    View in: PubMed
    Score: 0.003
  51. The experimental Alzheimer's disease drug posiphen [(+)-phenserine] lowers amyloid-beta peptide levels in cell culture and mice. J Pharmacol Exp Ther. 2007 Jan; 320(1):386-96.
    View in: PubMed
    Score: 0.003
  52. Neurine, an acetylcholine autolysis product, elevates secreted amyloid-beta protein precursor and amyloid-beta peptide levels, and lowers neuronal cell viability in culture: a role in Alzheimer's disease? J Alzheimers Dis. 2006 Sep; 10(1):9-16.
    View in: PubMed
    Score: 0.003
  53. Increased App expression in a mouse model of Down's syndrome disrupts NGF transport and causes cholinergic neuron degeneration. Neuron. 2006 Jul 06; 51(1):29-42.
    View in: PubMed
    Score: 0.003
  54. Identification of novel small molecule inhibitors of amyloid precursor protein synthesis as a route to lower Alzheimer's disease amyloid-beta peptide. J Pharmacol Exp Ther. 2006 Aug; 318(2):855-62.
    View in: PubMed
    Score: 0.003
  55. Selective butyrylcholinesterase inhibition elevates brain acetylcholine, augments learning and lowers Alzheimer beta-amyloid peptide in rodent. Proc Natl Acad Sci U S A. 2005 Nov 22; 102(47):17213-8.
    View in: PubMed
    Score: 0.003
  56. An overview of phenserine tartrate, a novel acetylcholinesterase inhibitor for the treatment of Alzheimer's disease. Curr Alzheimer Res. 2005 Jul; 2(3):281-90.
    View in: PubMed
    Score: 0.003
  57. New therapeutic strategies and drug candidates for neurodegenerative diseases: p53 and TNF-alpha inhibitors, and GLP-1 receptor agonists. Ann N Y Acad Sci. 2004 Dec; 1035:290-315.
    View in: PubMed
    Score: 0.002
  58. Differential expression of cholesterol hydroxylases in Alzheimer's disease. J Biol Chem. 2004 Aug 13; 279(33):34674-81.
    View in: PubMed
    Score: 0.002
  59. Functional characterization of the 5' flanking region of the BACE gene: identification of a 91 bp fragment involved in basal level of BACE promoter expression. FASEB J. 2004 Jun; 18(9):1037-9.
    View in: PubMed
    Score: 0.002
  60. Thalidomide-based TNF-alpha inhibitors for neurodegenerative diseases. Acta Neurobiol Exp (Wars). 2004; 64(1):1-9.
    View in: PubMed
    Score: 0.002
  61. 17beta-estradiol reduces plasma Abeta40 for HRT-na?ve postmenopausal women with Alzheimer disease: a preliminary study. Am J Geriatr Psychiatry. 2003 Mar-Apr; 11(2):239-44.
    View in: PubMed
    Score: 0.002
  62. A critical analysis of new molecular targets and strategies for drug developments in Alzheimer's disease. Curr Drug Targets. 2003 Feb; 4(2):97-112.
    View in: PubMed
    Score: 0.002
  63. Characterization of recombinant, soluble beta-secretase from an insect cell expression system. Mol Pharmacol. 2001 Mar; 59(3):619-26.
    View in: PubMed
    Score: 0.002
  64. Antisense-induced reduction of presenilin 1 expression selectively increases the production of amyloid beta42 in transfected cells. J Neurochem. 1999 Dec; 73(6):2383-8.
    View in: PubMed
    Score: 0.002
  65. Glycosylphosphatidylinositol-anchor intermediates associate with triton-insoluble membranes in subcellular compartments that include the endoplasmic reticulum. Biochem J. 1999 Nov 01; 343 Pt 3:627-35.
    View in: PubMed
    Score: 0.002
  66. Release of nontransmembrane full-length Alzheimer's amyloid precursor protein from the lumenar surface of chromaffin granule membranes. Biochemistry. 1998 Feb 03; 37(5):1274-82.
    View in: PubMed
    Score: 0.001
  67. The effect of tacrine and leupeptin on the secretion of the beta-amyloid precursor protein in HeLa cells. Life Sci. 1997; 61(20):1985-92.
    View in: PubMed
    Score: 0.001
  68. Evidence that secretase cleavage of cell surface Alzheimer amyloid precursor occurs after normal endocytic internalization. J Neurosci Res. 1995 Apr 01; 40(5):694-706.
    View in: PubMed
    Score: 0.001
  69. Cellular processing and proteoglycan nature of amyloid precursor proteins. Ann N Y Acad Sci. 1993 Sep 24; 695:132-8.
    View in: PubMed
    Score: 0.001
  70. The genesis of the senile plaque. Further evidence in support of its neuronal origin. Am J Pathol. 1992 Nov; 141(5):1151-9.
    View in: PubMed
    Score: 0.001
  71. Increased biosynthesis of Alzheimer amyloid precursor protein in the cerebral cortex of rats with lesions of the nucleus basalis of Meynert. Brain Res Mol Brain Res. 1991 May; 10(2):173-8.
    View in: PubMed
    Score: 0.001
  72. Human retina D2 receptor cDNAs have multiple polyadenylation sites and differ from a pituitary clone at the 5' non-coding region. Nucleic Acids Res. 1990 Mar 11; 18(5):1299.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.